학술논문

Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection.
Document Type
article
Source
The Journal of infectious diseases. 221(4)
Subject
Vagina
Humans
Chlamydia trachomatis
Gardnerella vaginalis
Lactobacillus
Chlamydia Infections
Vaginosis
Bacterial
Azithromycin
RNA
Ribosomal
16S
Anti-Bacterial Agents
Treatment Outcome
Follow-Up Studies
Prospective Studies
Cross-Sectional Studies
Adolescent
Adult
Female
Young Adult
Microbiota
Chlamydia trachomatis
16S rRNA gene sequencing
antibiotics
longitudinal
sexually transmitted infection
vaginal microbiome
Sexually Transmitted Infections
Infectious Diseases
Development of treatments and therapeutic interventions
5.1 Pharmaceuticals
Infection
Good Health and Well Being
Biological Sciences
Medical and Health Sciences
Microbiology
Language
Abstract
We characterized the composition and structure of the vaginal microbiota in a cohort of 149 women with genital Chlamydia trachomatis infection at baseline who were followed quarterly for 9 months after antibiotic treatment. At time of diagnosis, the vaginal microbiota was dominated by Lactobacillus iners or a diverse array of bacterial vaginosis-associated bacteria including Gardnerella vaginalis. Interestingly, L. iners-dominated communities were most common after azithromycin treatment (1 g monodose), consistent with the observed relative resistance of L. iners to azithromycin. Lactobacillus iners-dominated communities have been associated with increased risk of C. trachomatis infection, suggesting that the impact of antibiotic treatment on the vaginal microbiota could favor reinfections. These results provide support for the dual need to account for the potential perturbing effect(s) of antibiotic treatment on the vaginal microbiota, and to develop strategies to protect and restore optimal vaginal microbiota.